Logo image of NGVT

INGEVITY CORP (NGVT) Stock Fundamental Analysis

NYSE:NGVT - US45688C1071 - Common Stock

57.89 USD
-0.66 (-1.13%)
Last: 9/3/2025, 8:04:00 PM
57.89 USD
0 (0%)
After Hours: 9/3/2025, 8:04:00 PM
Fundamental Rating

4

NGVT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. There are concerns on the financial health of NGVT while its profitability can be described as average. NGVT may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

NGVT had positive earnings in the past year.
NGVT had a positive operating cash flow in the past year.
In multiple years NGVT reported negative net income over the last 5 years.
Each year in the past 5 years NGVT had a positive operating cash flow.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.54%, NGVT is doing worse than 75.90% of the companies in the same industry.
With a Return On Equity value of -179.45%, NGVT is not doing good in the industry: 91.57% of the companies in the same industry are doing better.
With an excellent Return On Invested Capital value of 15.68%, NGVT belongs to the best of the industry, outperforming 97.59% of the companies in the same industry.
NGVT had an Average Return On Invested Capital over the past 3 years of 10.65%. This is above the industry average of 6.34%.
The last Return On Invested Capital (15.68%) for NGVT is above the 3 year average (10.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -11.54%
ROE -179.45%
ROIC 15.68%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

NGVT has a better Operating Margin (22.24%) than 90.36% of its industry peers.
NGVT's Operating Margin has declined in the last couple of years.
NGVT has a better Gross Margin (36.47%) than 78.31% of its industry peers.
In the last couple of years the Gross Margin of NGVT has declined.
Industry RankSector Rank
OM 22.24%
PM (TTM) N/A
GM 36.47%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

3

2. Health

2.1 Basic Checks

NGVT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for NGVT has been increased compared to 1 year ago.
Compared to 5 years ago, NGVT has less shares outstanding
NGVT has a worse debt/assets ratio than last year.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.37 indicates that NGVT is not a great score, but indicates only limited risk for bankruptcy at the moment.
NGVT has a Altman-Z score of 2.37. This is in the better half of the industry: NGVT outperforms 67.47% of its industry peers.
The Debt to FCF ratio of NGVT is 8.85, which is on the high side as it means it would take NGVT, 8.85 years of fcf income to pay off all of its debts.
NGVT has a Debt to FCF ratio of 8.85. This is in the better half of the industry: NGVT outperforms 71.08% of its industry peers.
A Debt/Equity ratio of 10.24 is on the high side and indicates that NGVT has dependencies on debt financing.
NGVT's Debt to Equity ratio of 10.24 is on the low side compared to the rest of the industry. NGVT is outperformed by 91.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.24
Debt/FCF 8.85
Altman-Z 2.37
ROIC/WACC1.79
WACC8.74%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 1.36 indicates that NGVT should not have too much problems paying its short term obligations.
NGVT's Current ratio of 1.36 is on the low side compared to the rest of the industry. NGVT is outperformed by 80.72% of its industry peers.
A Quick Ratio of 0.80 indicates that NGVT may have some problems paying its short term obligations.
NGVT has a Quick ratio of 0.80. This is amonst the worse of the industry: NGVT underperforms 81.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.8
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

NGVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.17%, which is quite impressive.
The Earnings Per Share has been decreasing by -6.12% on average over the past years.
The Revenue for NGVT has decreased by -14.44% in the past year. This is quite bad
The Revenue has been growing slightly by 1.70% on average over the past years.
EPS 1Y (TTM)50.17%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%37.62%
Revenue 1Y (TTM)-14.44%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-6.53%

3.2 Future

NGVT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.68% yearly.
NGVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.48% yearly.
EPS Next Y26.79%
EPS Next 2Y18.61%
EPS Next 3Y17.68%
EPS Next 5YN/A
Revenue Next Year-7.63%
Revenue Next 2Y-1.43%
Revenue Next 3Y0.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.07 indicates a correct valuation of NGVT.
Based on the Price/Earnings ratio, NGVT is valued a bit cheaper than 78.31% of the companies in the same industry.
NGVT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.84.
NGVT is valuated reasonably with a Price/Forward Earnings ratio of 11.49.
Based on the Price/Forward Earnings ratio, NGVT is valued a bit cheaper than the industry average as 75.90% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.48. NGVT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.07
Fwd PE 11.49
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

NGVT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NGVT is cheaper than 71.08% of the companies in the same industry.
NGVT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NGVT is cheaper than 83.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.05
EV/EBITDA 8.49
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

NGVT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NGVT's earnings are expected to grow with 17.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y18.61%
EPS Next 3Y17.68%

0

5. Dividend

5.1 Amount

No dividends for NGVT!.
Industry RankSector Rank
Dividend Yield N/A

INGEVITY CORP

NYSE:NGVT (9/3/2025, 8:04:00 PM)

After market: 57.89 0 (0%)

57.89

-0.66 (-1.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners103.35%
Inst Owner Change-1.2%
Ins Owners1.03%
Ins Owner Change20.18%
Market Cap2.11B
Analysts82
Price Target61.71 (6.6%)
Short Float %2.69%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.42%
Min EPS beat(2)17.23%
Max EPS beat(2)31.61%
EPS beat(4)4
Avg EPS beat(4)67.89%
Min EPS beat(4)17.23%
Max EPS beat(4)202.89%
EPS beat(8)6
Avg EPS beat(8)66.35%
EPS beat(12)8
Avg EPS beat(12)42.62%
EPS beat(16)11
Avg EPS beat(16)35.87%
Revenue beat(2)0
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-5.48%
Max Revenue beat(2)-2.47%
Revenue beat(4)0
Avg Revenue beat(4)-4.38%
Min Revenue beat(4)-5.75%
Max Revenue beat(4)-2.47%
Revenue beat(8)2
Avg Revenue beat(8)-1.9%
Revenue beat(12)3
Avg Revenue beat(12)-1.41%
Revenue beat(16)7
Avg Revenue beat(16)0.82%
PT rev (1m)16.91%
PT rev (3m)21.61%
EPS NQ rev (1m)6.9%
EPS NQ rev (3m)-1.41%
EPS NY rev (1m)4.58%
EPS NY rev (3m)4.71%
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)-1.57%
Revenue NY rev (1m)-1.84%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE 13.07
Fwd PE 11.49
P/S 1.59
P/FCF 14.05
P/OCF 9.8
P/B 17.49
P/tB N/A
EV/EBITDA 8.49
EPS(TTM)4.43
EY7.65%
EPS(NY)5.04
Fwd EY8.7%
FCF(TTM)4.12
FCFY7.12%
OCF(TTM)5.91
OCFY10.2%
SpS36.33
BVpS3.31
TBVpS-4.46
PEG (NY)0.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.54%
ROE -179.45%
ROCE 19.84%
ROIC 15.68%
ROICexc 16.53%
ROICexgc 20.7%
OM 22.24%
PM (TTM) N/A
GM 36.47%
FCFM 11.35%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
ROICexc(3y)11.07%
ROICexc(5y)11.72%
ROICexgc(3y)17.77%
ROICexgc(5y)19.74%
ROCE(3y)13.49%
ROCE(5y)13.72%
ROICexcg growth 3Y-8.19%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-1.67%
ROICexc growth 5Y-0.8%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 10.24
Debt/FCF 8.85
Debt/EBITDA 3.12
Cap/Depr 63.89%
Cap/Sales 4.91%
Interest Coverage 3.67
Cash Conversion 54.33%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 0.8
Altman-Z 2.37
F-Score5
WACC8.74%
ROIC/WACC1.79
Cap/Depr(3y)97.35%
Cap/Depr(5y)93.69%
Cap/Sales(3y)6.85%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.17%
EPS 3Y-11.81%
EPS 5Y-6.12%
EPS Q2Q%37.62%
EPS Next Y26.79%
EPS Next 2Y18.61%
EPS Next 3Y17.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.44%
Revenue growth 3Y0.36%
Revenue growth 5Y1.7%
Sales Q2Q%-6.53%
Revenue Next Year-7.63%
Revenue Next 2Y-1.43%
Revenue Next 3Y0.48%
Revenue Next 5YN/A
EBIT growth 1Y39.49%
EBIT growth 3Y-5.83%
EBIT growth 5Y-2.78%
EBIT Next Year58.9%
EBIT Next 3Y22.85%
EBIT Next 5YN/A
FCF growth 1Y25.77%
FCF growth 3Y-35.4%
FCF growth 5Y-20.53%
OCF growth 1Y-14.49%
OCF growth 3Y-24%
OCF growth 5Y-14.15%